The FDA has given the green light for the marketing of mobile medical apps that securely and accurately share information on patients' blood glucose levels with their doctors in real time. The apps give caregivers remote access to the data.
The FDA has given the green light for the marketing of mobile medical apps that securely and accurately share information on patients' blood glucose levels with their doctors in real time. The apps give caregivers remote access to the data.